共 15 条
[1]
Experimental destruction of substantia nigra initiated by Parkinson disease immunoglobulins. Chen SD,Le WD,Xie WJ,et al. Archives of Neurology . 1998
[2]
Neuropathology in mice expressing human alphasynuclein. Van der Putten H,Wiederhold KH,Probst A,et al. The Journal of Neuroscience . 2000
[3]
Animal models of parkinsonism using selective neurotoxins: clinical and basic implications. Zigmond MJ,Stricker EM. International Review of Neurobiology . 1989
[4]
Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Masliah E,Rockenstein E,Veinbergs I,et al. Science . 2000
[5]
Study on MPTPinduced parkinsonian animal model in rhesus monkey and the mechanism of MPTP. Chen SD,Xu DL,Yu HZ,et al. Chinese Medical Journal . 1988
[6]
Hemiparkinsonism in monkeys following unilateral common carotid artery infusion of MPTP: behavior , biochemistry and histology. Chen SD,Zhou XD,Xu DL,et al. Chinese Medical Journal . 1991
[7]
1-methyl -4phenyl -1, 2, 3, 6-tetrahydropyridine ( MPTP) induced parkinsonism in the cat : behavioral biochemical and pathological studies. Chen SD,Zhou XD,Xu DL,et al. Chinese Medical Sciences Journal . 1993
[8]
Animal models of Parkinson’ s disease. Betarbet R,Sherer TB,Greenamyre JT. Bioessays . 2002
[9]
The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson’ s disease. Thiruchelvam M,Richfield EK,Baggs KB,et al. The Journal of Neuroscience . 2000
[10]
Dosedependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6hydroxydopamine. Przedborski S,Levivier M,Ferreira M,et al. Neuroscience . 1995